Amgen's LUMAKRAS approved in Japan for the treatment of non-small cell lung cancer patients with KRAS G12C mutations
20 January 2022 - 9:57PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Apr 2023 to Apr 2024